127 Improved patient-specific optimization of the stopping power calibration for proton therapy planning using a single optimized proton radiography  by Krah, N. et al.
S62  ICTR-PHE 2016 
 
 
Keywords: AGuIX nanoparticles, imaged-guided radiotherapy, 
radiosensitization. 
 
References: 
[1] Siegel RL, Amos RA, Jemal A. Cancer Statistics, 2015. CA 
Cancer Jan 1;65(1)5-29. 
[2] Lux F, Mignot A, Mowat P, et al. Ultrasmall rigid particles 
as multimodal probes for medical applications. Angewandte 
chemie 50(51) :12299-12303. 
[3] Sancey L, Lux F, Kotb S, et al. The use of theranostic 
gadolinium-based nanoprobes to improve radiotherapy 
efficacy. Br J Radiol.2014. 
[4] Sancey L & Kotb S, Truillet C, et al. Long-term in vivo 
clearance of gadolinium-based AGuIX nanoparticles and their 
biocompatibility after systemic injection. ACS Nano. 2015 
Mar 24;9(3):2477-88. 
[5] Kotb S, Detappe A, Lux F, et al. Gadolinium-based 
nanoparticles and radiation therapy for multiple brain 
melanoma metastases: proof of concept before phase I trial. 
Theranostics (under consideration). 
 
126 
Development of the Flair tool for FLUKA Treatment 
Planning Verification 
W. Kozłowska1,2, T. Böhlen3, A. Ferrari1, D. Georg2,4, A. 
Mairani5,6 , P. Sala1,7, V. Vlachoudis1 
1 CERN, Geneva, Switzerland 
2 M Department of Radiation Oncology, Division of Medical 
Radiation Physics Medical University of Vienna, Vienna, 
Austria 
3 EBG MedAustron GmbH, Wiener Neustadt, Austria 
4 Christian Doppler Laboratory for Medical Radation Research, 
Medical University of Vienna/AKH Vienna, Austria 
5 CNAO, Pavia, Italy 
6 HIT Heidelberg, Germany 
7 INFN Sezione di Milano, Milan, Italy 
 
Outcome of radiation therapy depends on accurate, robust 
and verified calculations of the planned dose. Monte Carlo 
(MC) is considered as the gold standard for dosimetric 
calculations, however its popularity in a clinical environment 
is still limited. One of the reasons is the typically complex 
procedure of setting the patient models and beam 
parameters. The focus of physical models development in the 
FLUKA [1][2] MC code, since many years, is put on the 
medical area, making it an ideal tool applicable for the 
nuclear medicine and hadron-therapy simulations. It is 
already used in the clinical environment in HIT and CNAO for 
generating Treatment Planning System (TPS) databases and 
offline treatment verification. The aim of this work is to 
present the recent improvements of FLUKA and its Graphical 
User Interface - Flair [3] providing a fully-functional and 
easy-to-use tool for quality assurance (QA) of treatment 
plans for protons, carbon and other light ion species. 
In this study we present the most recent developments, 
based on several re-calculations of complete proton/ion 
treatment plans from different TPS and facilities using Flair 
and FLUKA. FLUKA recently was enhanced with the RBE 
estimator and dedicated PET, prompt-gamma and charged 
particles scoring for beam range verification. To better 
utilize these advantages, Flair facilitates the application of 
the treatment scheme into the simulation procedure. It is 
able to import the CT DICOM images creating the voxel-
phantom geometries based on parameterization according to 
Schneider et al[4]. Flair allows importing the entire 
treatment scheme directly from the RT DICOM files, such as 
RTSTRUCT, RTDOSE and RTPLAN. To better comply with the 
real irradiation settings, Flair incorporates also the basis 
characteristics of the beam delivery system with the minimal 
effort from the user point of view. 
Several comparisons were made between the TPS and the 
FLUKA simulation scheme. The DVH plots for the PTV/OAR 
shows good agreement for the presented cases; some dose 
deposition differences in various tissues are noticeable, 
especially in the end of the ranges of the beam particles. 
FLUKA physical models were thoroughly validated, hence, 
quantification and identification of the discrepancies, 
especially taking into consideration more complex cases – like 
patients/organs with the more heterogeneous structures, 
may bring a great value for the treatment quality. 
Additional, independent re-calculation is always an asset, 
and usage of FLUKA and its efficient graphical user interface 
Flair, can enhance the popularity of the MC in the clinical 
environment for both research and QA purposes. 
The presented results will be used for further work on the 
tool development, assuring the quality of the treatment 
plans and providing the user with the guidelines for the 
treatment plan optimization. 
 
 
Fig: Flair screenshot of the comparison between TPS and 
FLUKA simulations 
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Purpose: We present an improved method to calculate 
patient-specific calibration curves to convert X-ray computed 
tomography (CT) Hounsfield Unit (HU) to relative stopping 
powers (RSP) for proton therapy treatment planning. We 
introduce also an optimization method to improve the spatial 
resolution and the water equivalent thickness (WET) accuracy 
of proton radiographies [1].  
Materials/Methods: By optimizing the HU-RSP calibration 
curve, the difference between a proton radiographic image 
and a digitally reconstructed X-ray radiography (DRR) is 
minimized. The feasibility of this approach has previously 
been demonstrated [2,3]. This scenario assumes that all 
discrepancies between proton radiography and DRR originate 
from uncertainties in the HU-RSP curve. In reality, external 
factors cause imperfections in the proton radiography, such 
as misalignment compared to the DRR and unfaithful 
representation of geometric structures (“blurring”). We 
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analyze these effects based on synthetic datasets of 
anthropomorphic phantoms and suggest an extended 
optimization scheme which explicitly accounts for these 
effects. Performance of the method is been tested for 
various simulated irradiation parameters.  
We also investigate the use of a special optimization method 
to enhance the spatial resolution and the WET accuracy of 
proton radiographies prior to the HU-RSP re-calibration. The 
optimization method is designed for imaging systems 
measuring only the residual range of protons without relying 
on tracker detectors to determine the beam trajectory 
before and after the target.   
The ultimate purpose of the optimization is to minimize 
uncertainties in the HU-RSP calibration curve. We therefore 
suggest and perform a thorough statistical treatment to 
quantify the accuracy of the optimized HU-RSP curve. 
Results: We demonstrate that without extending the 
optimization scheme, spatial blurring (equivalent to 
FWHM=3mm convolution) in the proton radiographies can 
cause up to 10% deviation between  the optimized and the 
ground truth HU-RSP calibration curve. Instead, results 
obtained with our extended method reach 1% or better 
correspondence, as shown in Figure 1. We have further 
calculated gamma index maps for different acceptance 
levels. With DTA=0.5mm and RD=0.5%, a passing ratio of 100% 
is obtained with the extended method, while an optimization 
neglecting effects of spatial blurring only reach ~90%.  
Conclusions: Our contribution underlines the potential of a 
single optimized proton radiography to generate a patient-
specific calibration curve and to improve dose delivery by 
optimizing the HU-RSP calibration curve as long as all sources 
of systematic incongruence are properly modeled.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1: Comparison of optimized conversion curves.  
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Prostate Cancer is one of the leading cancer entities in men, 
however. In this disease, radiotherapy leads to comparable 
cure rates compared to surgery. Overall, survival and cure 
rates of patients with prostate cancer are on average much 
higher than in many other cancers. Despite this fact, 
biological individualization of treatment is also an important 
research topic in this disease. Specifically in the field of 
personalized radiation oncology important research questions 
include: 1) pre-treatment identification of patient subgroups 
with individually very radioresistant tumours that would have 
a high risk of recurrence after standard radiotherapy alone. 
2) pre-treatment identification of subgroups that have a high 
chance of tumour cure after radiotherapy alone 3) 
identification of subgroups with a high risk of distant 
metastasis after local treatment 
Definition of biomarkers to identify such patient subgroups 
need to consider biochemical failure, local recurrences and 
distant metastases. Biomarkers will in future help to 
individualize radiation dose, but also combined radiation and 
systemic treatments. All endpoints need to be compared with 
surgical patient groups, with the mid-term aim to find 
decision parameters between the two treatment approaches. 
The talk will give an overview over current candidate 
biomarkers in preclinical and translational research. 
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Purpose: The J-PET collaboration is developing a novel TOF-
PET, whole-body tomography scanner based on polymer 
scintillators [1-4]. The scanner barrel is made of long 
scintillators, axially positioned, which are readout from both 
sides by photomultipiers. This novel approach relies mainly 
on the timing of the signals instead of their amplitudes for 
the reconstruction of the Lines-of-Response, therefore a very 
precise time resolution is one of the main challenges of the 
project.  
Material and methods: For this purpose, novel ultrafast front-
end electronics (FFE) allowing for sampling in the voltage 
domain of the signals with a duration of few nanosecond was 
developed [5]. The FEE solution is a purely digital 
implementation, based solely on a FPGA (Field Programmable 
